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CPD Questionnaire
 CPD@SA Family Practice
Earn 100% of your required CEU points by completing the SA FAMILY PRACTICE CPD questionnaire each month.
2007 ANSWER SHEETS
CPD QUESTIONNAIRES MUST NOW BE COMPLETED ONLINE AT
www.safpj.co.za
 1.  Simply click on the “CPD” icon below the journal masthead.  You will be directed to the CPD questionnaire on the www.ecpdsa.co.za website.
 2.  Click on the SA Family Practice Volume 49(2) March 2007 activity listed on the “Choose a CPD activity” page.
 3.  You will be prompted to login on the ecpdsa website.  Click on “Register” on the top menu bar if you have not registered on ecpdsa before, or simply Log In.
 4.  Click on “Continue” at the bottom of the “CPD Activity” page to view the CPD questions.  Complete the questions online.  If successful, you will receive your CPD certificate 
online.
 5.  If you experience any problems, kindly contact Léhane at Tel:  (021) 975 4684, Fax: 086 500 4974, or Email: cpd@ecpdsa.co.za
 6.  If you return the completed CPD answer sheet by fax or email your answers will be entered on the www.ecpdsa.co.za website.  If successful, your CPD certificate will be available 
on ecpdsa, or returned to you on request.
 Please note this is a FREE service to members of the SA Academy of Family Practice/Primary Care and subscribers to the journal only.
 Thank you very much for your cooperation.










































































































Question 1-3: Combination therapy in hypertension: Page 22-24
True False
1. The combination of a beta-blocker and a non-dihydropyridine CCB could lead to significant bradycardia 
and heart block.
2. Any hypertensive patient with a presenting blood pressure above 180/110 mmHg should be started on 
combination therapy.
3. The combination of a beta-blocker and a diuretic may predispose a patient to new-onset diabetes.
Question 4-5: Shingles: Page 27-28
4. Varicella vaccination is effective to prevent disease in 80-85% of cases and will prevent severe disease 
in 95% cases.
5. Antiviral therapy reduces pain and may prevent post-herpetic neuralgia.
Question: 6-14: Overactive bladder: Page 31-36
6. Trospium is a fat soluble drug.
7. Solifenacin and darfenacin are bladder selective.
8. Pelvic floor muscle training and bladder training may be more effective than medication in motivated 
patients.
9. Extended release tolteridine seems to be more effective than the immediate-release formulations.
10. Anticholinergic therapy may increase the maximal cystometric volume by 100 ml, resulting in three less 
episodes of incontinence and two less voids in 48 hours. 
11. Trospium is better tolerated than immediate-release oxybutynin.
12. Solifenacin is more effective than tolteridine.
13. Darifenacin increases “warning time” by 10.7 minutes.
14. M3-receptors can be found on smooth muscles in the GI-tract, salivary glands, eyes and brain.
Question 15-20: Opportunistic infections in HIV infected infants and children: Page 40-45
15. HIV infected children should be vaccinated with live attenuated vaccinations like polio, BCG and mea-
sles.
16. HIV infected children will not benefit from conjugated pneumococcal, varicella and flu vaccines.
17. Absent light reflexes, “floaters” and impairment of visual acuity in a severely immunocompromised child 
should raise the suspicion for CMV retinitis.
18. Oral herpes simplex ulceration for longer than 4 weeks is an AIDS-defining condition.
19. Impairment of speech, vision and mental deterioration may be signs of progressive multifocal leukoen-
cephalopathy. 
20. A negative Indian ink test in suspected cases of cryptococcus neoformans meningitis should be con-
firmed by an antigen test.
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